Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 19, 2025, Aclaris Therapeutics (ACRS) has a market cap of $0.12 billion USD. According to our data, Aclaris Therapeutics is ranked No.7416 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 19, 2025 | $0.12 B |
-53.55%
|
| Dec 31, 2024 | $0.27 B |
136.19%
|
| Dec 29, 2023 | $0.11 B |
-93.33%
|
| Dec 30, 2022 | $1.69 B |
8.32%
|
| Dec 31, 2021 | $1.56 B |
124.73%
|
| Dec 31, 2020 | $0.69 B |
242.33%
|
| Dec 31, 2019 | $0.20 B |
-74.42%
|
| Dec 31, 2018 | $0.79 B |
-70.03%
|
| Dec 29, 2017 | $2.64 B |
-9.14%
|
| Dec 30, 2016 | $2.90 B |
0.74%
|
| Dec 31, 2015 | $2.88 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Journey Medical
DERM
|
$0.14 B |
37.500 M
|
USA
|
 Revance Therapeutics
RVNC
|
$0.38 B |
0.000 M
|
USA
|
 Incyte
INCY
|
$11.27 B |
0.000 M
|
USA
|
 Verrica Pharmaceuticals
VRCA
|
$45.02 M |
-0.046 M
|
USA
|
 Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
USA
|
 Pfizer
PFE
|
$125.57 B |
0.001 M
|
USA
|
 Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
USA
|
 AbbVie
ABBV
|
$306.02 B |
0.008 M
|
USA
|
 Amgen
AMGN
|
$149.09 B |
0.124 B
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
USA
|
 Biogen
BIIB
|
$17.36 B |
-0.001 M
|
USA
|
 Novartis
NVS
|
$219.89 B |
0.932 B
|
Switzerland
|
 Sanofi
SNY
|
$124.64 B |
0.327 B
|
France
|
| Market Cap | = | ACRS Stock Price | * | ACRS Shares Outstanding |
| = | $1.14 | * | 0.11 B | |
| = | $0.12 B |